Open-label trial to evaluate dopamine transporter occupancy in the human brain following repeated oral administration of OPC-64005 in healthy adult male subjects
Latest Information Update: 14 Jun 2016
At a glance
- Drugs OPC 64005 (Primary)
- Indications Depression
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 14 Jun 2016 New trial record
- 07 Apr 2016 Status changed from recruiting to completed